Rishi Gupta
Listed on 7 Form D filings across 6+ issuers
· Director, Executive Officer
Associated issuers
- Dravite Therapeutics, Inc. CIK 2133272 · California
- Wilshire Selective Opportunities Program SPC - WilSOP Segregated Portfolio 5 CIK 2126973 · Cayman Islands
- Delfi Diagnostics, Inc. CIK 1783735 · California
- Golden Teak Capital L.P. CIK 1777119 · California
- CHARM Therapeutics Inc. CIK 1889676 · United Kingdom
- Aer Therapeutics, Inc. CIK 1959576 · North Carolina
Filings (7)
-
Dravite Therapeutics, Inc.D · Sep 3, 2026 · California · Other$53MView filing →
-
Wilshire Selective Opportunities Program SPC - WilSOP Segregated Portfolio 5D · May 8, 2026 · Cayman Islands · Pooled Investment Fund
-
Delfi Diagnostics, Inc.D · Dec 18, 2025 · California · Biotechnology$60MView filing →
-
Golden Teak Capital L.P.D/A · Dec 16, 2025 · California · Pooled Investment Fund
-
CHARM Therapeutics Inc.D · Sep 3, 2025 · United Kingdom · Other$80.1MView filing →
-
Aer Therapeutics, Inc.D · Feb 7, 2025 · North Carolina · Biotechnology$5MView filing →
-
Golden Teak Capital L.P.D/A · Jan 3, 2025 · California · Pooled Investment Fund